Results of the TACT study finally proved that chelation therapy is safe and very effective. Outcomes were fewer deaths, fewer heart attacks, and fewer strokes, less need for cardiovascular surgery, and fewer hospitalizations for heart problems. In particular, patients with diabetes had great improvement.
Specifically, forty 3-hour intravenous infusions of disodium EDTA were administered during 30 weekly sessions, followed by 10 more treatments given once per month. All patients in the study had previously suffered a heart attack.
Heart disease is the leading cause of death for both men and women in the United States. The risk of coronary heart disease can be reduced by taking steps to prevent and control those adverse factors that put people at greater risk. Contact me to address potential risk factors such as poor diet and nutrition, hormone imbalance, toxic metal burden in the body, and to discuss the possibility of IV EDTA chelation for prevention and treatment.